Exhibit 1: Increasing Importance of the Biologic Medicines Market Source: IQVIA MIDAS® Q4 2020, IQVIA Institute analysis using Pipeline Intelligence Exhibit Notes: Biologic medicines are defined as innovative biologic molecules and innovative biologics. Other medicines category includes innovative small molecules and generics. Exhibit 2: Biosimilars as a Portion of the Accessible Biologics Market European biosimilar share within the accessible market (treatment days, absolute value, % market share) Source: IQVIA Impact of Biosimilar Competition Report 2020 Exhibit Notes: Accessible market includes referenced medicines and non-referenced medicines across major therapy areas available for biosimilar competition. Therapy areas include GCSFs, EPO, HGH, fertility, insulins, LLMW